166 related articles for article (PubMed ID: 20334438)
1. Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells.
Pennington K; Peng J; Hung CC; Banks RE; Robinson PA
J Proteome Res; 2010 May; 9(5):2390-401. PubMed ID: 20334438
[TBL] [Abstract][Full Text] [Related]
2. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
[TBL] [Abstract][Full Text] [Related]
3. Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein.
Zhong J; Li M; Xu J; Dong W; Qin Y; Qiu S; Li X; Wang H
Toxicol Appl Pharmacol; 2022 Feb; 436():115859. PubMed ID: 34990728
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.
Xun Z; Sowell RA; Kaufman TC; Clemmer DE
Mol Cell Proteomics; 2008 Jul; 7(7):1191-203. PubMed ID: 18353766
[TBL] [Abstract][Full Text] [Related]
6. Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells.
Perfeito R; Lázaro DF; Outeiro TF; Rego AC
Mol Cell Neurosci; 2014 Sep; 62():51-9. PubMed ID: 25109238
[TBL] [Abstract][Full Text] [Related]
7. Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.
Melo TQ; van Zomeren KC; Ferrari MF; Boddeke HW; Copray JC
Exp Brain Res; 2017 Mar; 235(3):731-742. PubMed ID: 27866262
[TBL] [Abstract][Full Text] [Related]
8. iTRAQ-based quantitative proteomics study on the neuroprotective effects of extract of Acanthopanax senticosus harm on SH-SY5Y cells overexpressing A53T mutant α-synuclein.
Li XZ; Zhang SN; Wang KX; Liu SM; Lu F
Neurochem Int; 2014 Jun; 72():37-47. PubMed ID: 24795107
[TBL] [Abstract][Full Text] [Related]
9. Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.
Chorfa A; Bétemps D; Morignat E; Lazizzera C; Hogeveen K; Andrieu T; Baron T
Toxicol Sci; 2013 Jun; 133(2):289-97. PubMed ID: 23535362
[TBL] [Abstract][Full Text] [Related]
10. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
Moussa CE; Wersinger C; Tomita Y; Sidhu A
Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K.
Choong CJ; Say YH
Neurotoxicology; 2011 Dec; 32(6):857-63. PubMed ID: 21658409
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.
Martin LJ; Pan Y; Price AC; Sterling W; Copeland NG; Jenkins NA; Price DL; Lee MK
J Neurosci; 2006 Jan; 26(1):41-50. PubMed ID: 16399671
[TBL] [Abstract][Full Text] [Related]
13. Effect of trehalose on PC12 cells overexpressing wild-type or A53T mutant α-synuclein.
Lan DM; Liu FT; Zhao J; Chen Y; Wu JJ; Ding ZT; Yue ZY; Ren HM; Jiang YP; Wang J
Neurochem Res; 2012 Sep; 37(9):2025-32. PubMed ID: 22707286
[TBL] [Abstract][Full Text] [Related]
14. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
[TBL] [Abstract][Full Text] [Related]
15. alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells.
Hettiarachchi NT; Parker A; Dallas ML; Pennington K; Hung CC; Pearson HA; Boyle JP; Robinson P; Peers C
J Neurochem; 2009 Dec; 111(5):1192-201. PubMed ID: 19860837
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein Overexpression Induces Lysosomal Dysfunction and Autophagy Impairment in Human Neuroblastoma SH-SY5Y.
Nascimento AC; Erustes AG; Reckziegel P; Bincoletto C; Ureshino RP; Pereira GJS; Smaili SS
Neurochem Res; 2020 Nov; 45(11):2749-2761. PubMed ID: 32915398
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells.
Perfeito R; Ribeiro M; Rego AC
Arch Toxicol; 2017 Mar; 91(3):1245-1259. PubMed ID: 27424009
[TBL] [Abstract][Full Text] [Related]
18. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors.
Wislet-Gendebien S; Visanji NP; Whitehead SN; Marsilio D; Hou W; Figeys D; Fraser PE; Bennett SA; Tandon A
BMC Neurosci; 2008 Sep; 9():92. PubMed ID: 18808659
[TBL] [Abstract][Full Text] [Related]
20. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]